Filed Pursuant to Rule 424(b)(5)
Registration No. 333-227641
The information in this preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended but is not complete and may be changed.
Subject to Completion
Preliminary Prospectus Supplement dated June 24, 2019
PROSPECTUS SUPPLEMENT
(To Prospectus dated October 1, 2018)
90,000,000 Shares

VICI Properties Inc.
Common Stock
We are selling 30,000,000 shares of our common stock, par value $0.01 per share, or our common stock.
In addition, we expect to enter into forward sale agreements with each of BofA Securities, Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC (or their respective affiliates), which we refer to in this capacity as the forward purchasers. In connection with the forward sale agreements, the forward purchasers or their respective affiliates are borrowing from third parties and selling to the underwriters an aggregate of 60,000,000 shares of common stock that will be sold in this offering. We will not initially receive any proceeds from the sale of our common stock by the forward purchasers or their respective affiliates.
We expect to physically settle the forward sale agreements (by the delivery of shares of our common stock) and receive proceeds from the sale of those shares of common stock on one or more forward settlement dates no later than approximately 15 months after the date of this prospectus supplement. We may also elect to cash settle or net share settle all or a portion of our obligation under the forward sale agreements if we conclude that it is in our best interest to do so. If we elect to cash settle the forward sale agreements, we may not receive any cash proceeds, and we may be required to pay cash to the forward purchasers in certain circumstances. If we elect to net share settle the forward sale agreements, we will not receive any cash proceeds, and we may be required to deliver shares of common stock to the forward purchasers in certain circumstances. See “Underwriting—Forward Sale Agreements.”
If any forward purchaser or its affiliate does not sell on the anticipated closing date of this offering all of the shares of our common stock that it has agreed to sell to the underwriters after using commercially reasonable efforts, we will issue and sell to the underwriters a number of shares of our common stock equal to the number of shares of common stock that such forward purchaser or its affiliate does not sell, and the number of shares of common stock underlying the relevant forward sale agreement will be decreased by the number of shares of common stock that we issue and sell.
Our common stock is listed on the New York Stock Exchange (the “NYSE”) under the symbol “VICI.” On June 21, 2019, the closing price of our common stock as reported on the NYSE was $22.79 per share.
We have elected to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes commencing with our taxable year ended December 31, 2017. To assist us in maintaining our status as a REIT, among other purposes, our charter contains certain restrictions relating to the ownership and transfer of our shares and a provision generally restricting stockholders from owning more than 9.8% in value or in number, whichever is more restrictive, of any class or series of our shares, including the common stock offered hereby. In addition to the restrictions referred to in the immediately preceding sentence, ownership of our capital stock, including the common stock offered hereby, is subject to applicable gaming laws, and any person owning or controlling at least 5% of the outstanding shares of any class of our capital stock is required to promptly notify us of their identity. See “Description of Capital Stock—Restrictions on Ownership and Transfer” and “—Redemption of Securities Owned or Controlled by an Unsuitable Person or Affiliate” in the accompanying prospectus for a detailed description of the ownership, transfer and notification restrictions applicable to our common stock.
Investing in our common stock involves risks. You should read carefully and consider the “Risk Factors” beginning on pageS-10 of this prospectus supplement and the risk factors described in our Annual Report on Form10-K for the year ended December 31, 2018 (the “Annual Report”), which is incorporated herein by reference.
Neither the Securities and Exchange Commission nor any state or other securities commission has approved or disapproved these securities or passed upon the accuracy or adequacy of this prospectus supplement. Any representation to the contrary is a criminal offense.
| | | | | | | | |
| | Per Share | | | Total | |
Public offering price | | $ | | | | $ | | |
Underwriting discount(1) | | $ | | | | $ | | |
Proceeds, before expenses, to us(2) | | $ | | | | $ | | |
(1) | We refer you to “Underwriting” beginning on pageS-41 of this prospectus supplement for additional information regarding underwriting compensation. |
(2) | We expect to receive estimated aggregate proceeds, before expenses, of $ from the sale of the common stock in this offering by us and the forward purchasers or their respective affiliates. The amount of proceeds, if any, we may receive upon settlement of the forward sale agreements, which settlement we expect to occur no later than approximately 15 months after the date of this prospectus supplement, depends on numerous factors, including the settlement method, market interest rates and the prevailing market price of our common stock during the relevant period. For the purposes of calculating the aggregate proceeds to us from the sale of the common stock, we have assumed that the forward sale agreements are fully physically settled in one or more settlements based on an initial forward sale price of $ per share (which is the public offering price per share, less the underwriting discount per share). The forward sale price is subject to adjustment pursuant to the forward sale agreements, and the actual proceeds, if any, to us will be calculated as provided in the forward sale agreements (as described in this prospectus supplement). Although we expect to settle the forward sale agreements entirely by the physical delivery of our common stock in exchange for cash proceeds, we may elect cash settlement or net share settlement for all or a portion of our obligations under the forward sale agreements. See “Underwriting—Forward Sale Agreements.” |
We have granted the underwriters an option to purchase up to an additional 13,500,000 shares of common stock from us at the public offering price, less the underwriting discount, for 30 days after the date of this prospectus supplement.
The underwriters expect to deliver the shares of our common stock on or about June , 2019 through the facilities of The Depository Trust Company.
| | | | | | |
BofA Merrill Lynch | | Deutsche Bank Securities | | Goldman Sachs & Co. LLC | | Morgan Stanley |
The date of this prospectus supplement is June , 2019